0001209191-21-045640.txt : 20210706
0001209191-21-045640.hdr.sgml : 20210706
20210706184931
ACCESSION NUMBER: 0001209191-21-045640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210706
DATE AS OF CHANGE: 20210706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Urso David M
CENTRAL INDEX KEY: 0001604256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 211075676
MAIL ADDRESS:
STREET 1: C/O MEI PHARMA, INC.
STREET 2: 11975 EL CAMINO REAL, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-369-7100
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-01
0
0001262104
MEI Pharma, Inc.
MEIP
0001604256
Urso David M
C/O MEI PHARMA, INC.
11455 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
0
1
0
0
Chief Operating Officer & GC
Common Stock
2021-07-02
4
F
0
24825
2.94
D
49281
D
Stock Option (Right to Buy)
2.95
2021-07-01
4
A
0
600000
0.00
A
2031-07-01
Common Stock
600000
600000
D
Stock Option (Right to Buy)
1.57
2025-07-28
Common Stock
127500
127500
D
Stock Option (Right to Buy)
1.36
2026-07-29
Common Stock
130000
130000
D
Stock Option (Right to Buy)
2.83
2027-07-06
Common Stock
130000
130000
D
Stock Option (Right to Buy)
4.33
2028-06-22
Common Stock
130000
130000
D
Stock Option (Right to Buy)
4.28
2028-07-12
Common Stock
220000
220000
D
Stock Option (Right to Buy)
2.52
2029-07-01
Common Stock
350000
350000
D
Stock Option (Right to Buy)
3.49
2030-07-02
Common Stock
525000
525000
D
Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
All of such options are presently exercisable.
One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
/s/ Brian G. Drazba, as attorney in fact
2021-07-06